These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

901 related items for PubMed ID: 23402452

  • 1. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A.
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [Abstract] [Full Text] [Related]

  • 2. The impact of non-severe hypoglycemic events on work productivity and diabetes management.
    Brod M, Christensen T, Thomsen TL, Bushnell DM.
    Value Health; 2011 Feb; 14(5):665-71. PubMed ID: 21839404
    [Abstract] [Full Text] [Related]

  • 3. Economic impact of hypoglycemia on healthcare in Spain.
    Brito-Sanfiel M, Diago-Cabezudo J, Calderon A.
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):649-60. PubMed ID: 21155698
    [Abstract] [Full Text] [Related]

  • 4. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
    Giorda CB, Rossi MC, Ozzello O, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Romeo F, Lucisano G, Nicolucci A, HYPOS-1 Study Group of AMD.
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies.
    Xie L, Wei W, Pan C, Baser O.
    J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Technology and the issue of cost/benefit in diabetes.
    Giannini C, Mohn A, Chiarelli F.
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
    Nicolucci A, Rossi MC, D'Ostilio D, Delbaere A, de Portu S, Roze S.
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
    [Abstract] [Full Text] [Related]

  • 16. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT, Brnabic AJ, Eggleston A, Kolivos A, McBride ME, Schrover R, Jones TW.
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.